Showing results (281-290 of 351) with videos related to

Sort By:
Pageof 36
Oncotarget|June 2, 2016
Tumor acidosis enhances cytotoxic effects and autophagy inhibition by salinomycin on cancer cell lines and cancer stem cellsPaola Pellegrini, Matheus Dyczynski, Francesca Vittoria Sbrana, et al.
JAMA|November 9, 2016
Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical TrialTheodoros Foukakis, Gunter von Minckwitz, Nils-Olof Bengtsson, et al.
Radiology|May 23, 2023
Standalone AI for Breast Cancer Detection at Screening Digital Mammography and Digital Breast Tomosynthesis: A Systematic Review and Meta-AnalysisJung Hyun Yoon, Fredrik Strand, Pascal A T Baltzer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2015
First results of the preoperative accelerated partial breast irradiation (PAPBI) trialFemke van der Leij, Sophie C J Bosma, Marc J van de Vijver, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 28, 2024
Human Epidermal Growth Factor Receptor 2 (HER2) PET Imaging of HER2-Low Breast Cancer with [68Ga]Ga-ABY-025: Results from a Pilot StudyRenske Altena, Siri Af Burén, August Blomgren, et al.
The American Journal of Pathology|July 19, 2011
ERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancerYoshiya Horimoto, Johan Hartman, Julie Millour, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2021
TAp73 represses NF-κB-mediated recruitment of tumor-associated macrophages in breast cancerJohanna Wolfsberger, Habib A M Sakil, Leilei Zhou, et al.
The New England Journal of Medicine|September 16, 2024
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast CancerPeter Schmid, Javier Cortes, Rebecca Dent, et al.
Scientific Reports|December 20, 2019
CETSA-based target engagement of taxanes as biomarkers for efficacy and resistanceAnette Langebäck, Smaranda Bacanu, Henriette Laursen, et al.
NPJ Precision Oncology|December 4, 2025
Collaborative framework on responsible AI in LLM-driven CDSS for precision oncology leveraging real-world patient dataSonja Mathes, Dyke Ferber, Tobias Dreyer, et al.
Pageof 36